Investors look forward to a slew of economic data, including the jobs report due this Friday and the CPI report due next week. Also, several companies are scheduled to release their earnings reports. Quarterly reports of Nurix Therapeutics, Inc. (NRIX), Genius Brands International, Inc. (GNUS), and ClearSign Technologies Corporation (CLIR) are highly anticipated, but are these stocks worth the hype? Let’s find out in this article.
Despite the recent turmoil in the financial sector, the Federal Reserve raised interest rates by a quarter-point last month. The Fed has increased benchmark interest rates nine times since March 2022, taking the federal funds rates to a 4.75%-5% range. Fed Chairman Jerome Powell has hinted that rate hikes are nearly at an end.
